Résumé
La prévalence de l’altération du statut fonctionnel appréciée par plusieurs échelles chez le sujet agé atteint de cancer est fréquente et fonction du type de cancer et du moment de l’évaluation de l’autonomie. Avant traitement, l’autonomie du malade âgé cancéreux mesurée au cours de l’évaluation gériatrique approfondie (EGA) influence souvent la décision thérapeutique. Au cours du traitement anticancéreux, les études divergent quant aux effets du traitement sur le statut fonctionnel du patient âgé. Une perte d’autonomie est associée à une moins bonne tolérance au traitement anticancéreux avec davantage de complications mais les études ne permettent pas d’établir précisément le lien qui semble exister entre statut fonctionnel altéré et diminution de la survie. La dégradation de l’autonomie peut résulter à la fois de l’effet du vieillissement et de l’histoire carcinologique. Le lien fort entre autonomie et cancer rend nécessaire une évaluation fonctionnelle chez tout sujet âgé atteint d’un cancer.
Références
Yancik R, Ries LA. Cancer in older persons: an international issue in an aging word. Semin Oncol. 2004; 31(2): 128–136.
Christel Colin. Que nous apprend l’enquête HID sur les personnes agées dépendantes, aujourd’hui et demain ? Revue Française des Affaires Sociales. 2003; 1–2: 75–101.
Schag CC, Heinrich RL, Ganz PA.Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984; 2(3):187–193.
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5: 649–655.
Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983; 31: 721–727.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9: 179–186.
Reuben DB, Rubenstein LV, Hirsch SH et al. Value of functional status as predictor of mortality.Am J Med. 1992; 93: 663–669.
Monfardini S, Ferrucci L, Fratino L, et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer. 1996; 77: 395–401.
Repetto L, Fratino L, Riccardo A et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group Performance Status in elderly cancer patients: an italian group for geriatric oncology study. J Clin Oncol. 2002; 20(2): 494–502.
Stafford RS, Cyr PL.The impact of cancer on physical function of elderly and their utilization of health care. Cancer. 1997; 80: 1973–1980.
Ulander K, Jeppsson B, Grahn G.Quality of life and independence in activities of daily living preoperatively and follow-up in patients with colorectal cancer. Support Care Cancer. 1997; 5: 402–409.
Chen H, Cantor A, Meyer J, et al. Can older patients tolerate chemotherapy? A prospective pilot study. Cancer. 2003; 97: 1107–1114.
Mattioli R, Lippe P, Recchia F, et al.Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusion.Anticancer Res. 2001; 21(1A): 489–492.
Mattioli R, Massacesi C, Recchia F, et al. High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for eldrly patients with advenced colorectal cancer.Ann Oncol. 2005; 16(7): 1147–1151.
Rousseau F, Retornaz F, Joly F, et al. Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advenced solid tumours: a multicentre pilot study of the French geriatric oncology group (GERICO). Crit Rev Oncol Hematol. 2010; 76(1): 71–78.
Brain EG, Mertens C, Girre V, et al. Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: a French geriatric oncology group (GERICO) phase II multicenter trial. Crit Rev Oncol Hematol. 2010. [Epub ahead of print].
Sargent DJ, Köhne CH, Sanoff HK, et al. Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using indivudual data from patients with metastatic colorectal cancer. J Clin Oncol. 2009; 27: 1948–1955.
Wedding U, Röhrig B, Klippstein A, et al.Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol. 2007; 133: 945–950.
Forrest LM, McMillan DC, McArdle CS et al. A prospective longitudinal study of performans status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2005; 92: 1834–1836.
Maione P, Perrone F, Gallot C, et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol. 2005; 23(28): 6865–6872.
Garman KS, Pieper CF, Seo P, et al. Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci. 2003; 58(12):M1119–M1124.
Grov EK, Fossa SD, Dahl AA. Activity of daily living problems in older cancer survivors: a population-based controlled study. Health Soc Care Community. 2010; 18(4): 396–406.
Keating NL, Norredam M, Landrun MB, et al. Physical andmental health status of older long-term cancer survivors. JAGS. 2005; 53: 2145–2152.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Caillet, P., Mézière, A. & Paillaud, E. Dépendance et cancer chez le sujet âgé. cah. année gerontol. 3 (Suppl 1), 64 (2011). https://doi.org/10.1007/s12612-011-0207-0
Published:
DOI: https://doi.org/10.1007/s12612-011-0207-0